Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 3, 2009, Pages 261-267

  Spasenovski, Trajko ^a   Carroll, Mary P ^b   Payne, Matthew S ^a   Bruce, Kenneth D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

16S 23S rRNA ITS1; Cystic Fibrosis; Pseudomonas genus; T RFLP profiling

Indexed keywords

RIBOSOME RNA;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LUNG FIBROSIS; MICROBIAL DIVERSITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE CHARACTERIZED AMPLIFIED REGION; SEQUENCE HOMOLOGY; SPECIES DIFFERENTIATION;

ADULT; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DNA, RIBOSOMAL SPACER; HUMANS; LUNG; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 59649106110     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.11.011     Document Type: Article

References (35)

1. Aaron S.D., Ramotar K., Ferris W., Vandemheen K., Saginur R., Tullis E., Haase D., Kottachchi D., St Denis M., and Chan F. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 169 (2004) 811-815
2. Acinas A.I., Anton J., and Rodrigez-Valera F. Diversity of free-living and attached bacteria in off-shore Western Mediterranean waters as depicted by 16S rDNA analysis. Appl. Environ. Microbiol. 65 (1999) 514-522
3. Aumeran C., Paillard C., Robin F., Kanold J., Baud O., Bonnet R., Souweine B., and Traore O. Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J. Hosp. Infect. 65 (2007) 47-53
4. Borneman J., and Triplett E.W. Molecular microbial diversity in soils from Eastern Amazonia: evidence for unusual microorganisms and microbial population shifts associated with deforestation. Appl. Environ. Microbiol. 63 (1997) 2647-2653
5. Carpenter R.J., Hartzell J.D., Forsberg J.A., Babel B.S., and Ganesan A. Pseudomonas putida war wound infection in a US Marine: a case report and review of the literature. J. Infect. 56 (2008) 234-240
6. Christensen J.E., Reynolds C.E., Shukla S.K., and Reed K.D. Rapid molecular diagnosis of lactobacillus bacteremia by terminal restriction fragment length polymorphism analysis of the 16S rRNA gene. Clin. Med. Res. 2 (2008) 37-45
7. Conway S.P., Pond M.N., Bowler I., Smith D.L., Simmonds E.J., Joanes DN Hambleton G., Hiller E.J., Stableforth D.E., Weller P., and Littlewood J.M. The chest radiograph in cystic fibrosis: a new score system compared with the Chrispin-Norman and Brasfield scores. Thorax 49 (1994) 860-862
8. Drenkard E., and Ausubel F.M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416 (2002) 740-743
9. Govan J.R., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60 (1996) 539-574
10. Guasp C., Moore E., Lalucat J., and Bensar A. Utility of internally transcribed 16S-23S rDNA spacer regions for the definition of Pseudomonas stutzeri genomovars and other Pseudomonas species. Int. J. Syst. Evol. Microbiol. 50 (2000) 1629-1639
11. Gutiérrez O., Juan C., Cercenado E., Navarro F., Bouza E., Coll P., Pérez J.L., and Oliver A. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51 (2007) 4329-4335
12. Hsueh P.R., Teng L.J., Pan H.J., Chen Y.C., Sun C.C., Ho S.W., and Luh K.T. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J. Clin. microbiol. 36 (1998) 2914-2917
13. Kaplan C.W., Astaire J.C., Sanders M.E., Reddy B.S., and Kitts C.L. 16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 67 (2001) 1935-1939
14. Karpati F., and Jonasson J. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Mol. Cell. Probes 10 (1996) 397-403
15. Kresse A.U., Dinesh S.D., Larbig K., and Römling U. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 47 (2003) 145-158
16. Lee T.W.R., Brownlee K.G., Conway S.P., Denton M., and Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2 (2003) 29-34
17. Liu W.T., Marsh T.L., Cheng H., and Forney L.J. Characterization of microbial diversity by determining terminal restriction fragment length polymorphism's of genes encoding 16S rRNA. Appl. Environ. Microbiol. 63 (1997) 4516-4522
18. Locatelli L., Tarnawski J., Harmelin A., Rossi P., Aragno M., and Fromon N. Specific PCR amplification for the genus Pseudomonas targeting the 3′ half of 16S rDNA and the whole 16S-23S rDNA spacer. Syst. Appl. Microbiol. 25 (2002) 220-227
19. Lyczak J.B., Cannon C., and Pier G. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15 (2002) 194-222
20. Mert A., Yilmaz M., Ozaras R., Kocak F., and Dagsali S. Native valve endocarditis due to Pseudomonas mendocina in a patient with mental retardation and a review of literature. Scand. J. Infect. Dis. 39 (2007) 615-616
21. Natalini E., and Scortichini M. Variability of the 16S-23S rRNA gene internal transcribed spacer in Pseudomonas avellanae strains. FEMS Microbiol. Lett. 271 (2007) 274-280
22. Paschoal I.A., Vilalba W., Bertuzzo C.S., Cerqueira E.M., and Pereira M.C. Cystic fibrosis in adults. Lung 185 (2007) 81-87
23. Pérez-Luz S., Adela Yanez M., and Catalan V. Identification of waterborne bacteria by the analysis of 16S-23S rRNA intergenic spacer region. J. Appl. Microbiol. 97 (2004) 191-200
24. Perry J.D., Laine L., Hughes S., Nicholson A., Galloway A., and Gould F.K. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media. J. Antimicrob. Chemother. 61 (2008) 1057-1061
25. Reisler R.B., and Blumberg H. Community-acquired Pseudomonas stutzeri vertebral osteomyelitis in a previously healthy patient: case report and review. Clin. Infect. Dis. 29 (1999) 667-669
26. Rocap G., Distel D.L., Waterbury J.B., and Chisholm S.W. Resolution of Prochlorococcus and Synechococcus ecotypes by using 16S-23S ribosomal DNA internal transcribed spacer sequences. Appl. Environ. Microbiol. 68 (2001) 1180-1191
27. Rogers G.B., Hart C.A., Mason J.R., Hughes M., Walshaw M.J., and Bruce K.D. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 41 (2003) 3548-3558
28. Saiman L., and Siegel J. Infection control in cystic fibrosis. Clin. Micro. Rew. 17 (2004) 57-71
29. Sakamoto M., Hayashi H., and Benno Y. Terminal restriction fragment length polymorphism analysis for human faecal microbiota and its application for analysis of complex bifidobacterial communities. Microbiol. Immunol. 47 (2003) 133-142
30. Sikorski J., Lalucat J., and Wackernagel W. Genomovars 11 and 18 of Pseudomonas stutzeri, identified among isolates from soil and marine sediment. Int. J. Syst. Evol. Microbiol. 55 (2005) 1767-1770
31. Silbert S., Barth A.L., and Sader H.S. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J. Clin. Microbiol. 39 (2001) 3976-3981
32. Spilker T., Coenye T., Vandamme P., and Li Puma J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol. 42 (2004) 2074-2079
33. Tyler S.D., Strathdee K.R., Rozee K.R., and Johnson W.M. Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin. Diagn. Lab. Immunol. 2 (1995) 448-453
34. van Belkum A., Renders N., Smith S., Overbeek S.E., and Verbrugh H.A. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. FEMS Immunol. Med. Microbiol. 27 (2000) 51-57
35. Wellinghausen N., Köthe J., Wirths B., Sigge A., and Poppert S. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical, from patients with cystic fibrosis. J. Clin. Microbiol. 43 (2005) 4070-4075